-
The Real-World Impact of Step Therapy and Prior Authorization on Patients, Clinicians, and US Health Plans: Lessons to Be Learned in Europe
Sep 9, 2025, 16:22 PM -
NICE Decisions in the Southwest Quadrant
Sep 9, 2025, 16:22 PM -
Clinical Outcomes In HTA Appraisal Reports Of Oncology Medicines In Portugal: A Cross-Sectional Analysis
Sep 9, 2025, 16:22 PM -
Mental and Behavioral Health Disorders MBHD Among Patients With Metastatic and Nonmetastatic Cancer: A Claims-Based Analysis
Sep 9, 2025, 16:22 PM -
Adjuvanted RSVpreF3 Vaccine for Respiratory Syncytial Virus Prevention in the United Kingdom, Spain, and Australia: A Climate Change Impact Analysis
Sep 9, 2025, 16:22 PM -
The Effects of Pooling Treatment Effects Targeting Treatment Policy and Hypothetical Estimands With Rank-Preserving Structural Failure Time Model in Oncology Aggregate-Level Meta-Analyses
Sep 9, 2025, 16:22 PM -
Quantifying the Economic Burden of Osteoarthritis in Portugal: Insights From a Patient Journey Model
Sep 9, 2025, 16:22 PM -
Capturing the Realities of Hematological Cancer Patients’ Experiences of Novel Immunotherapies: A Call for Alignment and Action to Improve PROM Within CAR-T and Bispecific Antibody Therapies
Sep 9, 2025, 16:22 PM -
Definitive Staging and Perioperative Treatment for Resectable Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC): A UK Perspective
Sep 9, 2025, 16:22 PM -
Effect of the Inflation Reduction Act on Drug Innovation
Sep 9, 2025, 16:22 PM -
A Cross-Sectional Analysis of the Reimbursement Obligation for CAR-T Drugs by Huiminbao Insurances in Mainland China of 2024
Sep 9, 2025, 16:22 PM -
Integrating Environmental Sustainability Into Cost-Effectiveness Analysis and Value Demonstration: A Multidimensional Framework
Sep 9, 2025, 16:22 PM -
Expert Consensus on the Clinical and Economic Value of Advanced Wound-Care Products in Mexico: Results From a Delphi Panel
Sep 9, 2025, 16:22 PM -
Efficacy and Safety of Nalbuphine Compared With Analgesics for Moderate to Severe Postoperative Pain: A Systematic Review and Network Meta-Analysis
Sep 9, 2025, 16:22 PM -
An Economic Evaluation to Inform the Use of Enhanced Influenza Vaccines for Those Aged 65 Years and Older in the Seasonal Influenza Vaccination Program in Ireland
Sep 9, 2025, 16:22 PM -
Methods for the Economic Evaluation of Health Impacts of Climate Action: When, Why, and How Best to Use Them? A Literature Review
Sep 9, 2025, 16:22 PM -
The Value of Rare Pediatric Disease Designation Program for Decision Making by Drug Developers
Sep 9, 2025, 16:22 PM -
Exploring LLMs in the Conceptual and Functional Construction of Health Economic Models: A Case Study on Alzheimer's Diagnostic Cost-Effectiveness Model
Sep 9, 2025, 16:22 PM -
Evaluation of the Effectiveness of Targeted Radiofrequency Therapy in Impingement Syndrome
Sep 9, 2025, 16:22 PM -
Exploration of the Utility of Linguistic Validation Cognitive Debriefing Interviews in Generating Evidence for Adding or Modifying Source COA Content
Sep 9, 2025, 16:22 PM
